<DOC>
	<DOC>NCT01396668</DOC>
	<brief_summary>This is a phase â…¡ trial of fixed dose rate gemcitabine and cisplatin chemotherapy followed by chemoradiation with capecitabine in patients with locally advanced pancreatic cancer.</brief_summary>
	<brief_title>Fixed Dose Rate Gemcitabine and Cisplatin Followed by Chemoradiation for Locally Advanced Pancreatic Cancer</brief_title>
	<detailed_description>The main purpose of this study is to evaluate the efficacy and safety of fixed dose rate gemcitabine and cisplatin chemotherapy followed by chemoradiation with capecitabine in patients with locally advanced pancreatic cancer.</detailed_description>
	<mesh_term>Pancreatic Neoplasms</mesh_term>
	<mesh_term>Gemcitabine</mesh_term>
	<mesh_term>Cisplatin</mesh_term>
	<mesh_term>Capecitabine</mesh_term>
	<criteria>unresectable locally advanced pancreatic cancer no distant metastasis histologically confirmed adenocarcinoma of pancreas 1875 of age ECOG performance status 02 normal marrow function : WBC at least 3,000/mm3 OR Absolute neutrophil count at least 1,500/mm3 Platelet count at least 100,000/mm3 normal liver function : Bilirubin no greater than 2.0 mg/dL AST less than 3 times upper limit of normal (ULN) normal renal function : Creatinine no greater than 1.5 times ULN signed informed consent</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>July 2011</verification_date>
	<keyword>locally advanced</keyword>
</DOC>